-

Nation’s PFAS Leader, Eurofins, Expands Reporting to 75 Compounds

LUXEMBOURG--(BUSINESS WIRE)--Eurofins Environment Testing America (Paris:ERF) has become the only commercial environmental laboratory to have the capability of reporting up to 75 PFAS target analytes, 70 from a single injection in potable and non-potable water. This achievement comes after increasing testing capacity in 2020 to meet the high demand of PFAS analysis, offering expedited turnaround times as short as 1 day. This expansive analyte list is the most comprehensive in the nation. With over 30 dedicated PFAS instruments, Eurofins currently holds the largest PFAS capacity in North America.

Polyfluoroalkyl Substances (PFAS) refer to a group of man-made compounds that can persist in the environment, bioaccumulate and biomagnify in wildlife. In recent years, PFAS have come under scrutiny for their adverse health impacts. As demand for PFAS testing has increased, Eurofins has been a leader in matching the demand and providing clients with the technology necessary to expand the testing landscape.

With 20 years of experience, Eurofins’ environment testing laboratories utilize gold-standard methodology to support PFAS analysis and analyze an extensive list of matrices for PFAS contamination. This list includes but is not limited to: potable and non-potable water; soils, sediments and biosolids; leachate; biota, tissue and vegetation; AFFF; concrete; dispersants, viscous liquids and micro-powders; commercial products such as carpeting, packaging and other items; and foods and dairy. Eurofins list of 75 compounds goes beyond testing for common replacement chemicals GenX, DONA and F-53B and provides insight into the next generation of PFAS. This capability, combined with specialty testing such as PFAS in source air emissions and ambient air, Total Oxidizable Precursors (TOP) Assay, Total Organofluorine, and Non-Targeted Analysis, provides the most comprehensive picture of PFAS contamination to date.

For further information please visit www.EurofinsPFAS.com

About Eurofins Environment Testing America
The Eurofins Environment Testing network in the US contributes to a clean and safe environment by providing market-leading laboratory testing, monitoring and consulting services to a wide range of industrial companies, environmental consultants, contractors, retailers and government authorities.

About Eurofins – the global leader in bio-analysis
Eurofins is Testing for Life. With over 50,000 staff across a network of more than 800 laboratories in over 50 countries, Eurofins’ companies offer a portfolio of over 200,000 analytical methods.

Eurofins Shares are listed on Euronext Paris Stock Exchange.

Contacts

Eurofins Scientific

BOURSE:ERF

Release Versions

Contacts

More News From Eurofins Scientific

Eurofins Scientific SE: Weekly Report on Share Repurchases from 02nd February to 06th February 2026

LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: Eurofins Scientific SE (Paris:ERF): Name of the Issuer Identify code of the Issuer Transaction day Identify code of the financial instrument Total daily volume (in number of shares) Daily weighted average purchase price of the shares Market (MIC Code) EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 02/02/2026 FR0014000MR3 10 000 68.3375 XPAR EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 03/02/2026 FR0014000MR3 10 000 67.9091 XPAR EUROFINS SCIENTIFIC 529900JEHFM...

Eurofins Viracor BioPharma Expands Bioanalytical Capabilities

LUXEMBOURG--(BUSINESS WIRE)--Eurofins Viracor BioPharma Services, a long‑standing and trusted partner for clinical trial testing solutions with deep expertise in specialty biomarkers and molecular assays, announces a significant expansion of its service portfolio with the addition of enhanced bioanalytical testing capabilities. These new services are fully aligned with Good Laboratory Practices (GLP) and Good Clinical Practices (GCP), enabling the company to enhance support of biopharmaceutical...

Eurofins CDMO Alphora Joins International Consortium Project to Advance Next Generation ADC Expression Platform

MISSISSAUGA, Ontario--(BUSINESS WIRE)--Eurofins CDMO Alphora is pleased to announce that its Canadian-based division is receiving advisory services and funding from the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP) to support a research and development collaboration project focused on advancing a transformative approach for next-generation ADC (antibody-drug conjugate) production to meet the growing demand for targeted therapeutics. As part of this initia...
Back to Newsroom